Fabrication and in vitro characterization of macroporous WS2/ bioactive glass scaffolds for biomedical applications

Simple item page
dc.contributor.authorEnsoylu M.
dc.contributor.authorAtmaca H.
dc.contributor.authorDeliormanlı A.M.
dc.date.accessioned2024-07-22T08:04:42Z
dc.date.available2024-07-22T08:04:42Z
dc.date.issued2022
dc.description.abstractIn the study, tungsten disulfide nanoparticle-containing (0.1 to 2 weight%) macroporous bioactive glass composites were prepared by polymer foam replication method. Their morphological, structural, mechanical properties as well as in vitro bioactivity and cytotoxicity against osteoblastic cells were investigated. Drug release behavior of gentamicin-loaded composite scaffolds was also analyzed in phosphate-buffered saline. Results indicated that the formation of tungsten trioxide/tungsten disulfide heterostructures in sintered glass samples contains tungsten disulfide at high concentrations. Incorporation of tungsten disulfide nanoparticles (at 0.5 weight%) to the bioactive glass matrix as reinforcing material improved the compressive strength of the composites through stress transfer mechanism. Additionally, tungsten disulfide addition enhanced the in vitro bioactivity and biocompatibility of the scaffolds at a specified concentration range. Results also revealed that the presence of tungsten disulfide nanoparticles did not affect the drug release behavior significantly. All of the composite scaffolds examined in the study demonstrated burst release in the first 24 h. Gentamicin release kinetics were found to be best fitted with the first-order kinetic model for all of the scaffolds. It was concluded that composite scaffolds fabricated in the study have potential to be used in bone tissue engineering applications. © 2022, The Author(s) under exclusive licence to Australian Ceramic Society.
dc.identifier.DOI-ID10.1007/s41779-021-00696-w
dc.identifier.issn25101560
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12805
dc.language.isoEnglish
dc.publisherSpringer
dc.subjectBioactive glass
dc.subjectBiocompatibility
dc.subjectBiomechanics
dc.subjectCompressive strength
dc.subjectControlled drug delivery
dc.subjectFabrication
dc.subjectFoams
dc.subjectMedical applications
dc.subjectNanoparticles
dc.subjectScaffolds (biology)
dc.subjectTargeted drug delivery
dc.subjectTungsten compounds
dc.subjectBiomedical applications
dc.subjectComposite scaffolds
dc.subjectDrug-release behaviour
dc.subjectGlass composites
dc.subjectGlass scaffolds
dc.subjectIn-vitro
dc.subjectIn-vitro bioactivity
dc.subjectMacroporous
dc.subjectPolymer foams
dc.subjectVitro characterization
dc.subjectSulfur compounds
dc.titleFabrication and in vitro characterization of macroporous WS2/ bioactive glass scaffolds for biomedical applications
dc.typeArticle

Files

Collections

Scopus Koleksiyonu